A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

United States

Memorial Sloan Kettering at Basking Ridge (Consent only), Basking Ridge, New Jersey

Memorial Sloan Kettering Monmouth (Consent only), Middletown, New Jersey

Memorial Sloan Kettering Bergen (Consent only), Montvale, New Jersey

Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack, New York

Memorial Sloan Kettering Westchester (Consent only), Harrison, New York